Teva Pharmaceutical's CEO Levin Resigns

Oct. 30, 2013

Teva Pharmaceutical Industries Ltd., one of the world's largest generic drugmakers, said President and CEO Jeremy Levin has agreed to resign less than two years into the job. The Israeli company named Chief Financial Officer Eyal Desheh an interim replacement and formed a committee to start searching for a permanent successor. Read the full story